FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37185876> ?p ?o ?g. }

• Q37185876 description "article científic" @default.
• Q37185876 description "article scientifique" @default.
• Q37185876 description "articolo scientifico" @default.
• Q37185876 description "artigo científico" @default.
• Q37185876 description "artículu científicu espublizáu en 2013" @default.
• Q37185876 description "bilimsel makale" @default.
• Q37185876 description "scientific article published on 13 August 2013" @default.
• Q37185876 description "vedecký článok" @default.
• Q37185876 description "vetenskaplig artikel" @default.
• Q37185876 description "videnskabelig artikel" @default.
• Q37185876 description "vědecký článek" @default.
• Q37185876 description "wetenschappelijk artikel" @default.
• Q37185876 description "wissenschaftlicher Artikel" @default.
• Q37185876 description "наукова стаття, опублікована в серпні 2013" @default.
• Q37185876 description "научни чланак" @default.
• Q37185876 description "مقالة علمية نشرت في 13 أغسطس 2013" @default.
• Q37185876 name "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 name "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 name "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 type Item @default.
• Q37185876 label "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 label "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 label "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 prefLabel "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 prefLabel "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 prefLabel "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours." @default.
• Q37185876 P1433 Q37185876-4B425769-5435-4034-8DFA-6A8D92D14362 @default.
• Q37185876 P1476 Q37185876-D109272D-2036-4400-BFC2-FA4703A3BE9A @default.
• Q37185876 P2093 Q37185876-1965650B-1EEA-4D55-97F9-E7A7356B2834 @default.
• Q37185876 P2093 Q37185876-36D6AD27-E070-4742-9890-E91F25AFC0A8 @default.
• Q37185876 P2093 Q37185876-404DCC05-CF2F-4188-B63D-CED2F42E8D69 @default.
• Q37185876 P2093 Q37185876-5AD2FE86-9580-4EDA-B4F8-F81EDE6A55E8 @default.
• Q37185876 P2093 Q37185876-62B74922-2B17-4880-882B-A9DC7425CCBC @default.
• Q37185876 P2093 Q37185876-7240A9C2-DFA1-4072-B348-DEA6018B3C06 @default.
• Q37185876 P2093 Q37185876-9467FCEC-9BA2-4FE8-B124-74BE7FD228E7 @default.
• Q37185876 P2093 Q37185876-960CD37D-5B3A-43CD-A77F-6AE38C1B55EB @default.
• Q37185876 P2093 Q37185876-B5025E23-B1D7-4613-8E2E-DDC8F3E399CF @default.
• Q37185876 P2093 Q37185876-B9595370-2C19-40E9-AD21-F3743201ABE2 @default.
• Q37185876 P2093 Q37185876-C759A717-5668-4BBA-B30A-D55170DBF4ED @default.
• Q37185876 P2860 Q37185876-01396646-71C2-4FAC-8CA0-C1ECB7F3855E @default.
• Q37185876 P2860 Q37185876-035C2AA4-4D5C-4239-A2A5-061E2CEED4BB @default.
• Q37185876 P2860 Q37185876-071CD820-2BE3-4E03-A1A4-8AC41BA50E82 @default.
• Q37185876 P2860 Q37185876-08B719C9-5C82-46CD-9E0D-B5154E2D39E2 @default.
• Q37185876 P2860 Q37185876-0C081ADA-283F-40A3-941A-908EDB91A147 @default.
• Q37185876 P2860 Q37185876-0C5024E5-51EB-474D-A4EB-B6BD76B73EC9 @default.
• Q37185876 P2860 Q37185876-0D0CEFFC-C610-4C2D-9514-5A8FA1F4FCA3 @default.
• Q37185876 P2860 Q37185876-0E5E012C-5019-4F67-88A7-EF04D2C85481 @default.
• Q37185876 P2860 Q37185876-145853AE-C329-4694-83BE-451D8D1E9221 @default.
• Q37185876 P2860 Q37185876-1C2664EA-F227-4351-BDEB-AB3F28CDAB2F @default.
• Q37185876 P2860 Q37185876-360E001C-02CE-4515-A4E5-0F844BA22695 @default.
• Q37185876 P2860 Q37185876-3A78198A-8400-40D8-8442-AB8C02E6E4CB @default.
• Q37185876 P2860 Q37185876-48EDC41A-CFF5-40DD-9632-F8C55C70D5DC @default.
• Q37185876 P2860 Q37185876-49B9A228-7D59-4584-AD46-C7C6EEF10B34 @default.
• Q37185876 P2860 Q37185876-49BE1214-49EE-4C4A-AABA-19406873C680 @default.
• Q37185876 P2860 Q37185876-4C85C752-A67A-41C2-955E-1217AEBF9C5E @default.
• Q37185876 P2860 Q37185876-51034F94-AB37-46F1-BD27-C38BD816EF0E @default.
• Q37185876 P2860 Q37185876-54D241EC-DC53-49E5-9341-D6BC2A153767 @default.
• Q37185876 P2860 Q37185876-575E9044-FB47-43E5-BDDD-4005CB40688D @default.
• Q37185876 P2860 Q37185876-5EF7D3AE-1ADD-4DE0-9F62-5DF41A58680C @default.
• Q37185876 P2860 Q37185876-6AD9A95F-0AC4-40D1-84A0-51C627237CD5 @default.
• Q37185876 P2860 Q37185876-6C08B71E-AA11-4952-AFA1-CFAE5CA0DB78 @default.
• Q37185876 P2860 Q37185876-75DEBC03-19CA-4205-85A5-4B9538C7C8DC @default.
• Q37185876 P2860 Q37185876-76CD55DB-06E1-43E1-BF7F-7EE314257B1F @default.
• Q37185876 P2860 Q37185876-7C140C9E-BB0D-4067-9D43-6BB284A57AB0 @default.
• Q37185876 P2860 Q37185876-7D0637B3-DEC1-40AC-B038-FF381F821611 @default.
• Q37185876 P2860 Q37185876-83FFFA0B-FECE-4BD0-9528-9A69BB9CC5B2 @default.
• Q37185876 P2860 Q37185876-95B9F36E-2574-4F10-9FC3-226D89B9006C @default.
• Q37185876 P2860 Q37185876-9E847693-05C2-4F28-969D-851167FC4A40 @default.
• Q37185876 P2860 Q37185876-AD77E8C1-B718-4490-B5A7-187B93B74D7A @default.
• Q37185876 P2860 Q37185876-B0AA9C7F-BF7E-4CF8-A9C6-4681FB932FED @default.
• Q37185876 P2860 Q37185876-BF67105E-2BF7-480E-8037-6AD1804D69B4 @default.
• Q37185876 P2860 Q37185876-C20AB368-8793-470E-86F4-794434C79430 @default.
• Q37185876 P2860 Q37185876-CEB18C3F-18D3-4C0B-A456-6E05BC3ED559 @default.
• Q37185876 P2860 Q37185876-D7137D28-F1EE-4B90-8B7B-02D6D88A25BD @default.
• Q37185876 P2860 Q37185876-E3E843DB-D1F0-4332-B94D-109E49ED4872 @default.
• Q37185876 P2860 Q37185876-E544EC95-541B-43D0-8987-258452D98F84 @default.
• Q37185876 P2860 Q37185876-E64AA3F1-148E-435D-8613-CB1CA09652DC @default.
• Q37185876 P2860 Q37185876-E685CA21-D84E-4FA2-9B89-481489953069 @default.
• Q37185876 P2860 Q37185876-F42A09EF-BCDB-4477-AD3C-D1921BE3E2EA @default.
• Q37185876 P2860 Q37185876-F96C6379-DDDF-446E-A6D4-EA62BDC0A2A2 @default.
• Q37185876 P2888 Q37185876-F3E5513F-C4F4-450D-865F-A59B0F8D5FB1 @default.
• Q37185876 P304 Q37185876-EF668253-5531-4A07-8FC6-DBBCC0A4C2D6 @default.
• Q37185876 P31 Q37185876-1C93BBE2-340C-4E9D-8620-A7225396B827 @default.
• Q37185876 P356 Q37185876-0384B21E-275B-4AD7-9D4A-B08A034934EC @default.
• Q37185876 P407 Q37185876-CCE00420-77B6-4B71-B4B3-249470ABDFBB @default.
• Q37185876 P433 Q37185876-3C1D9ABF-1241-40D5-B1F9-68EB25F32829 @default.
• Q37185876 P478 Q37185876-586BD522-A4E2-4C5C-AF4C-B59355ADA7CB @default.
• Q37185876 P50 Q37185876-0A9A411B-2A6C-44D5-AC4C-72C93F192A82 @default.
• Q37185876 P50 Q37185876-79109288-B281-4098-B823-7F49F91A49F5 @default.
• Q37185876 P577 Q37185876-7CC06074-F7C1-4E69-9627-319B4BF0A5AB @default.
• Q37185876 P5875 Q37185876-19C569B8-7CD3-4FBF-90F2-DDB465784804 @default.
• Q37185876 P698 Q37185876-81CA2D8F-44CF-438E-8D0A-67D357BC5333 @default.
• Q37185876 P921 Q37185876-526E986B-3113-4136-832E-47AD1E52FA4C @default.
• Q37185876 P932 Q37185876-254CF7AD-941D-4D8E-9406-C78F7608462E @default.
• Q37185876 P356 BJC.2013.474 @default.
• Q37185876 P698 23942080 @default.
• Q37185876 P1433 Q326309 @default.
• Q37185876 P1476 "A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours" @default.
• Q37185876 P2093 "A A Adjei" @default.
• Q37185876 P2093 "A Jimeno" @default.

• next